NeuroMetrix, Inc. - Common Stock (NURO)
4.3500
-0.0300 (-0.68%)
NeuroMetrix Inc. is a healthcare company that specializes in developing advanced medical technologies to improve the management of chronic pain and diabetes-related conditions
Their innovative products include non-invasive diagnostic and therapeutic devices that utilize neurostimulation and electrophysiology. By focusing on enhancing patient outcomes, the company aims to provide healthcare professionals with tools that facilitate accurate diagnosis and effective treatment strategies, ultimately alleviating the burden of pain and improving the quality of life for individuals suffering from these chronic conditions.
Frequently Asked Questions
Is NeuroMetrix, Inc. - Common Stock publicly traded?
Yes, NeuroMetrix, Inc. - Common Stock is publicly traded.
What exchange does NeuroMetrix, Inc. - Common Stock trade on?
NeuroMetrix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroMetrix, Inc. - Common Stock?
The ticker symbol for NeuroMetrix, Inc. - Common Stock is NURO on the Nasdaq Stock Market
What is the current price of NeuroMetrix, Inc. - Common Stock?
The current price of NeuroMetrix, Inc. - Common Stock is 4.350
When was NeuroMetrix, Inc. - Common Stock last traded?
The last trade of NeuroMetrix, Inc. - Common Stock was at 3:58 pm EST on February 5th, 2025
What is the market capitalization of NeuroMetrix, Inc. - Common Stock?
The market capitalization of NeuroMetrix, Inc. - Common Stock is 24.49M
How many shares of NeuroMetrix, Inc. - Common Stock are outstanding?
NeuroMetrix, Inc. - Common Stock has 5.63M shares outstanding.